fda warning letters compounding semaglutide october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compounded GLP-1s: Why doctors worry

Both groups exceeded 20%, and both had manageable side effect profiles

Design of potent and specific integrin antagonists peptide antagonists with high specificity for glycoprotein-IIbIIIa

Evidence: Green tea consumption is associated with lower serum folate in pregnant women Animal studies show neurodevelopmental effects from high-dose green tea Some studies report increased neural tube defect risk with daily tea consumption Who should avoid: Pregnant women (especially during the periconceptional period) Children with neurological or developmental issues Anyone with diagnosed cerebral folate deficiency Why Standard Treatment Falls Short The standard approach focuses almost entirely on prescription Leucovorin (folinic acid)typically 5-50 mg daily

In summary, the reported inactive GLP-1R crystal structure reveals a unique closed conformation of the ECD, and a deeper understanding of the conformational dynamics of GLP-1R was elaborated by EM and MD simulations

(2022) The quality and inflammatory index of the diet of patients with migraine

Short Takes Taken from C-SPAN's gavel-to-gavel coverage and condensed down to the key moments